{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:12:30Z","timestamp":1790475150056,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI16-00073"],"award-info":[{"award-number":["PI16-00073"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca&apos; Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.beem.2018.09.008","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:20:48Z","timestamp":1538144448000},"page":"941-954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Parathyroid hormone resistance syndromes \u2013 Inactivating PTH\/PTHrP signaling disorders (iPPSDs)"],"prefix":"10.1016","volume":"32","author":[{"given":"Francesca Marta","family":"Elli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrate","family":"Pereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Linglart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiomar","family":"Perez de Nanclares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.09.008_bib1","first-page":"1","article-title":"Screening for parathyroid hormone resistance in patients with non-phenotypically evident pseudohypoparathyroidism","author":"Todorova-Koteva","year":"2012","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.beem.2018.09.008_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06057","article-title":"Parathyroid hormone: past and present","volume":"187","author":"Potts","year":"2005","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2018.09.008_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2004.11.069","article-title":"Parathyroid hormone and parathyroid hormone-related peptide and their receptors","volume":"328","author":"Gensure","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coph.2005.07.004","article-title":"Parathyroid hormone \u2013 a bone anabolic and catabolic agent","volume":"5","author":"Poole","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","article-title":"Mammalian G proteins and their cell type specific functions","volume":"85","author":"Wettschureck","year":"2005","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.beem.2018.09.008_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/edrv-13-3-536","article-title":"Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction","volume":"13","author":"Spiegel","year":"1992","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.beem.2018.09.008_bib7","first-page":"2434","article-title":"Mutations in G proteins and G protein-coupled receptors in endocrine disease","volume":"81","author":"Spiegel","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.09.008_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1450543","article-title":"G\u00a0protein mutations in endocrine diseases","volume":"145","author":"Lania","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2018.09.008_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ncpendmet0324","article-title":"Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases","volume":"2","author":"Lania","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.008_bib10","first-page":"675","article-title":"Endocrine manifestations of stimulatory G protein \u03b1-subunit mutations and the role of genomic imprinting","volume":"22","author":"Weinstein","year":"2001","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0002-9343(83)91008-2","article-title":"Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein","volume":"74","author":"Levine","year":"1983","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2018.09.008_bib12","first-page":"653","article-title":"Multihormonal resistance to parathyroid hormone, thyroid stimulating hormone, and other hormonal and neurosensory stimuli in patients with pseudohypoparathyroidism","volume":"19","author":"Wemeau","year":"2006","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib13","first-page":"318","article-title":"Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type Ia","volume":"3","author":"Germain-Lee","year":"2006","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.beem.2018.09.008_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-3476(85)80189-X","article-title":"Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism type Ia","volume":"107","author":"Levine","year":"1985","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2018.09.008_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/eje.0.1480463","article-title":"A\u00a0new heterozygous mutation (L338N) in the human Gs\u03b1 (GNAS1) gene as a cause for congenital hypothyroidism in Albright's hereditary osteodystrophy","volume":"148","author":"Pohlenz","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.09.008_bib16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1515\/JPEM.2006.19.8.1049","article-title":"Pseudohypoparathyroidism type 1a with congenital hypothyroidism","volume":"19","author":"Pinsker","year":"2006","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1515\/JPEM.2006.19.S2.663","article-title":"Resistance to growth hormone releasing hormone and gonadotropins in Albright's hereditary osteodystrophy","volume":"19","author":"Mantovani","year":"2006","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib18","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1210\/jc.2002-022028","article-title":"Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs\u03b1 gene","volume":"88","author":"Mantovani","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib19","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/jc.2003-030028","article-title":"Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance","volume":"88","author":"Germain-Lee","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03347406","article-title":"GH secretion in a cohort of children with pseudohypoparathyroidism type Ia","volume":"30","author":"de Sanctis","year":"2007","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2015.03.029","article-title":"Multiple hormonal resistances: diagnosis, evaluation and therapy","volume":"76","author":"Linglart","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrendo.2016.52","article-title":"Pseudohypoparathyroidism and Gs\u03b1-cAMP-linked disorders: current view and open issues","volume":"12","author":"Mantovani","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2018.09.008_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jbmr.2070","article-title":"Postnatal establishment of allelic G\u03b1s silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous G\u03b1s disruption","volume":"29","author":"Turan","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib24","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2016-3544","article-title":"Progressive development of PTH resistance in patients with inactivating mutations on the maternal allele of GNAS","volume":"102","author":"Usardi","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.beem.2018.09.008_bib25","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1073\/pnas.95.15.8715","article-title":"Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene","volume":"95","author":"Yu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib26","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-16-0107","article-title":"From pseudohypoparathyroidism to inactivating PTH\/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network","volume":"175","author":"Thiele","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5034","key":"10.1016\/j.beem.2018.09.008_bib27","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A\u00a0G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","article-title":"Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands","volume":"26","author":"Murray","year":"2005","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02388725","article-title":"A\u00a0case of lethal congenital dwarfism with accelerated skeletal maturation","volume":"15","author":"Blomstrand","year":"1985","journal-title":"Pediatr Radiol"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddi001","article-title":"Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes","volume":"14","author":"Duchatelet","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.beem.2018.09.008_bib31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jc.2006-0300","article-title":"Novel mutations in the parathyroid hormone (PTH)\/PTH-related peptide receptor type 1 causing Blomstrand osteochondrodysplasia types I and II","volume":"92","author":"Hoogendam","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2018.09.008_bib32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jmedgenet-2015-103001","article-title":"Breakpoint mapping by whole genome sequencing identifies PTH2R gene disruption in a patient with midline craniosynostosis and a de novo balanced chromosomal rearrangement","volume":"52","author":"Kim","year":"2015","journal-title":"J\u00a0Med Genet"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ajhg.2008.11.006","article-title":"PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption","volume":"83","author":"Decker","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00784-013-1014-3","article-title":"Expanding the spectrum of PTH1R mutations in patients with primary failure of tooth eruption","volume":"8","author":"Roth","year":"2014","journal-title":"Clin Oral Invest"},{"issue":"12","key":"10.1016\/j.beem.2018.09.008_bib35","doi-asserted-by":"crossref","first-page":"E1489","DOI":"10.1152\/ajpendo.00254.2012","article-title":"Defective postnatal endochondral bone development by chondrocyte-specific targeted expression of parathyroid hormone type 2 receptor","volume":"303","author":"Panda","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib36","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0006-291X(80)90563-X","article-title":"Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism","volume":"94","author":"Levine","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"10.1016\/j.beem.2018.09.008_bib37","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199005173222002","article-title":"Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy","volume":"322","author":"Patten","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.beem.2006.09.001","article-title":"Mutations in the Gs alpha gene causing hormone resistance","volume":"20","author":"Mantovani","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ando.2015.03.004","article-title":"Acrodysostosis: a new form of pseudohypoparathyroidism?","volume":"76","author":"Silve","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.beem.2018.09.008_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ng.3302","article-title":"PDE3A mutations cause autosomal dominant hypertension with brachydactyly","volume":"47","author":"Maass","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.a.34393","article-title":"A\u00a0family of pseudohypoparathyroidism type Ia with an 850-kb submicroscopic deletion encompassing the whole GNAS locus","volume":"158A","author":"Mitsui","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib42","doi-asserted-by":"crossref","first-page":"E681","DOI":"10.1210\/jc.2014-3098","article-title":"Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms","volume":"100","author":"Garin","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mgg3.117","article-title":"A\u00a0positive genotype-phenotype correlation in a large cohort of patients with Pseudohypoparathyroidism Type Ia and Pseudopseudohypoparathyroidism and 33 newly identified mutations in the GNAS gene","volume":"3","author":"Thiele","year":"2015","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.22696","article-title":"GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders","volume":"36","author":"Lemos","year":"2015","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib45","first-page":"635","article-title":"Genetics of pseudohypoparathyroidism types Ia and Ic","volume":"19","author":"Aldred","year":"2006","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-105-2-197","article-title":"Mental deficiency in pseudohypoparathyroidism type I is associated with Ns-protein deficiency","volume":"105","author":"Farfel","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.09.008_bib47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archderm.1971.04000240058008","article-title":"Albright's hereditary osteodystrophy with cutaneous bone formation","volume":"104","author":"Eyre","year":"1971","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.beem.2018.09.008_bib48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/jmg.31.11.835","article-title":"Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy","volume":"31","author":"Wilson","year":"1994","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-8628(19980526)77:4<261::AID-AJMG2>3.0.CO;2-Q","article-title":"Pseudohypoparathyroidism type Ia from maternal but not paternal transmission of a Gsalpha gene mutation","volume":"77","author":"Nakamoto","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.beem.2018.09.008_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2106\/00004623-199403000-00013","article-title":"Progressive osseous heteroplasia: a distinct developmmental disorder of heterotopic ossification two new case reports and follow-up of three previously reported cases","volume":"74A","author":"Kaplan","year":"1994","journal-title":"J\u00a0Bone Joint Surg"},{"issue":"11","key":"10.1016\/j.beem.2018.09.008_bib51","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1359\/jbmr.2000.15.11.2074","article-title":"Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification","volume":"15","author":"Eddy","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"issue":"14","key":"10.1016\/j.beem.2018.09.008_bib52","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/ajmg.a.32346","article-title":"Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification","volume":"146A","author":"Adegbite","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.beem.2018.09.008_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJMoa011262","article-title":"Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia","volume":"346","author":"Shore","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.008_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bone.2013.06.015","article-title":"Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series","volume":"56","author":"Elli","year":"2013","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.beem.2018.09.008_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1010-5182(98)80048-6","article-title":"Congenital plate-like osteoma cutis of the forehead: an atypical presentation form","volume":"26","author":"Tresserra","year":"1998","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib56","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1210\/jc.2009-1451","article-title":"Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans","volume":"95","author":"Lebrun","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2018.09.008_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/humu.22265","article-title":"Pseudohypoparathyroidism type Ia and pseudopseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations","volume":"34","author":"Elli","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.09.008_bib58","first-page":"E277","article-title":"New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase","volume":"257","author":"Barret","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.beem.2018.09.008_bib59","first-page":"26","article-title":"Familial pseudohypoparathyroidism without somatic anomalies","volume":"123","author":"Winter","year":"1986","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.beem.2018.09.008_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005792-197603000-00001","article-title":"The spectrum of the hypoparathyroid states: a classification based on physiologic principles","volume":"55","author":"Nusynowitz","year":"1976","journal-title":"Medicine"},{"key":"10.1016\/j.beem.2018.09.008_bib61","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1210\/jc.2003-030393","article-title":"The stimulatory G protein \u03b1-subunit G s \u03b1 is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B","volume":"88","author":"Liu","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2018.09.008_bib62","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI10431","article-title":"A\u00a0GNAS1 imprinting defect in pseudohypoparathyroidism type IB","volume":"106","author":"Liu","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.beem.2018.09.008_bib63","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI19159","article-title":"Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS","volume":"112","author":"Bastepe","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1487","article-title":"Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib","volume":"37","author":"Bastepe","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.09.008_bib65","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/429932","article-title":"A\u00a0novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS","volume":"76","author":"Linglart","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.beem.2018.09.008_bib66","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2009-2205","article-title":"Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis","volume":"95","author":"Chillambhi","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.09.008_bib67","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2011-2804","article-title":"A\u00a0new deletion ablating NESP55 causes loss of maternal imprint of A\/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib","volume":"97","author":"Richard","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib68","doi-asserted-by":"crossref","first-page":"E724","DOI":"10.1210\/jc.2013-3704","article-title":"Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A\/B DMR","volume":"99","author":"Elli","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib69","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1210\/jc.2012-2639","article-title":"Pseudohypoparathyroidism type 1b due to paternal uniparental disomy of chromosome 20q","volume":"98","author":"Dixit","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2015.05.011","article-title":"Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B)","volume":"79","author":"Takatani","year":"2015","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.beem.2018.09.008_bib71","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/320117","article-title":"Paternal uniparental isodisomy of chromosome 20q--and the resulting changes in GNAS1 methylation--as a plausible cause of pseudohypoparathyroidism","volume":"68","author":"Bastepe","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.09.008_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13148-018-0449-4","article-title":"Mosaicism for GNAS methylation defects associated with pseudohypoparathyroidism type 1B arose in early post-zygotic phases","volume":"10","author":"Elli","year":"2018","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.beem.2018.09.008_bib73","series-title":"The radiology of bones and joints","author":"Brailsford","year":"1948"},{"key":"10.1016\/j.beem.2018.09.008_bib74","first-page":"2189","article-title":"Acrodysostosis","volume":"76","author":"Maroteaux","year":"1968","journal-title":"Presse Med"},{"key":"10.1016\/j.beem.2018.09.008_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archpedi.1971.02100140061002","article-title":"Acrodysostosis. A syndrome of peripheral dysostosis, nasal hypoplasia, and mental retardation","volume":"121","author":"Robinow","year":"1971","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.beem.2018.09.008_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00975340","article-title":"Acrodysostosis. A case of peripheral dysostosis, nasal hypoplasia, mental retardation and impaired hearing","volume":"7","author":"Reiter","year":"1978","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.beem.2018.09.008_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00019605-199210000-00003","article-title":"Familial acrodysostosis: can it be distinguished from Albright's hereditary osteodystrophy?","volume":"1","author":"Davies","year":"1992","journal-title":"Clin Dysmorphol"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib78","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/jbmr.2785","article-title":"Screening of PRKAR1A and PDE4D in a large Italian series of patients clinicaly diagnosed with Albright hereditary osteodystrophy and\/or pseudohypoparathyroidism","volume":"31","author":"Elli","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"issue":"23","key":"10.1016\/j.beem.2018.09.008_bib79","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa1012717","article-title":"Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance","volume":"364","author":"Linglart","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.008_bib80","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajhg.2012.03.003","article-title":"Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis","volume":"90","author":"Michot","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.09.008_bib81","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ajhg.2012.03.004","article-title":"Exome sequencing identifies PDE4D mutations in acrodysostosis","volume":"90","author":"Lee","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.09.008_bib82","doi-asserted-by":"crossref","first-page":"E1808","DOI":"10.1210\/jc.2012-1369","article-title":"PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance","volume":"97","author":"Nagasaki","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2018.09.008_bib83","doi-asserted-by":"crossref","first-page":"E2328","DOI":"10.1210\/jc.2012-2326","article-title":"PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance","volume":"97","author":"Linglart","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/humu.22222","article-title":"Identification of novel mutations confirms PDE4D as a major gene causing acrodysostosis","volume":"34","author":"Lynch","year":"2013","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.beem.2018.09.008_bib85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cge.12106","article-title":"Novel mutations of the PRKAR1A gene in patients with acrodysostosis","volume":"84","author":"Muhn","year":"2013","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.beem.2018.09.008_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jmedgenet-2013-101937","article-title":"Different mutations in PDE4D associated with developmental disorders with mirror phenotypes","volume":"51","author":"Lindstrand","year":"2014","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.beem.2018.09.008_bib87","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.cellsig.2014.07.025","article-title":"Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis","volume":"26","author":"Kaname","year":"2014","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.beem.2018.09.008_bib88","doi-asserted-by":"crossref","first-page":"13267","DOI":"10.3390\/ijms150813267","article-title":"The first mutation identified in a Chinese acrodysostosis patient confirms a p.G289E variation of PRKAR1A causes acrodysostosis","volume":"15","author":"Li","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2018.09.008_bib89","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/ajmg.a.36669","article-title":"Acroscyphodysplasia as a phenotypic variation of pseudohypoparathyroidism and acrodysostosis type 2","volume":"164A","author":"Mitsui","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.beem.2018.09.008_bib90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2214\/ajr.128.1.95","article-title":"Acrodysostosis coinciding with pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism","volume":"128","author":"Ablow","year":"1977","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.beem.2018.09.008_bib91","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1210\/jc.2011-1048","article-title":"Clinical review: pseudohypoparathyroidism: diagnosis and treatment","volume":"96","author":"Mantovani","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"225","key":"10.1016\/j.beem.2018.09.008_bib92","first-page":"1","article-title":"Acrodysostosis syndromes","volume":"1","author":"Silve","year":"2012","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.beem.2018.09.008_bib93","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.spinee.2013.06.107","article-title":"Spinal cord compression in pseudohypoparathyroidism","volume":"13","author":"Roberts","year":"2013","journal-title":"Spine J"},{"key":"10.1016\/j.beem.2018.09.008_bib94","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1210\/jc.2011-0013","article-title":"Increased prevalence of carpal tunnel syndrome in Albright hereditary osteodystrophy","volume":"96","author":"Joseph","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2018.09.008_bib95","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jbmr.3450","article-title":"Genetic and epigenetic defects at the GNAS locus lead to distinct patterns of skeletal growth but similar early-onset obesity","volume":"33","author":"Hanna","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib96","doi-asserted-by":"crossref","first-page":"E623","DOI":"10.1210\/jc.2014-4047","article-title":"Loss of methylation at GNAS exon A\/B is associated with increased intrauterine growth","volume":"100","author":"Br\u00e9hin","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2018.09.008_bib97","doi-asserted-by":"crossref","first-page":"E1549","DOI":"10.1210\/jc.2013-1667","article-title":"Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLas in fetal development","volume":"98","author":"Richard","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2018.09.008_bib98","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1210\/jc.2003-030850","article-title":"Brachydactyly in 14 genetically characterized pseudohypoparathyroidism type Ia patients","volume":"89","author":"de Sanctis","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib99","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1210\/jc.2012-1655","article-title":"Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B","volume":"97","author":"Neary","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.008_bib100","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1210\/jc.2010-1649","article-title":"Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth","volume":"95","author":"Mantovani","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2018.09.008_bib101","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of Pseudohypoparathyroidism and related disorders: first international consensus statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endoc"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:54:10Z","timestamp":1761497650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18301088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1521690X18301088"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.008","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid hormone resistance syndromes \u2013 Inactivating PTH\/PTHrP signaling disorders (iPPSDs)","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}